NCT06920511 · NOT YET RECRUITING

Cognitive Rehabilitation With Virtual Reality in Parkinson Disease

This pilot study is testing a robotic and virtual reality platform called PRoBio for cognitive rehabilitation in people with Parkinson's Disease who also have Mild Cognitive Impairment. Participants do three virtual cognitive training sessions per week for four weeks while sensors track their physical and physiological responses. Phase NA means this is a feasibility and usability study — the researchers are checking whether the system works and feels acceptable to patients, not yet proving clinical benefit.

Inclusion criteria

  • Diagnosis of mild Parkinson's Disease (Hoehn \& Yahr stage II-III);
  • Diagnosis of Mild Cognitive Impairment (MCI) according to Litvan et al. (2012) criteria for PD-MCI;
  • Age ≥ 18 years;
  • Signed informed consent

Exclusion criteria

  • Diagnosis of Parkinson's Disease Dementia, atypical parkinsonisms, secondary parkinsonisms, or mixed forms;
  • Severe depressive syndrome
  • Absence of signed informed consent

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-04-09

View full record on ClinicalTrials.gov

All APOE4 clinical trials